\n\u201eNu se pot fabrica vaccinuri \u015fi medicamente de ultim\u0103 genera\u0163ie \u00een \u0163ar\u0103, Rom\u00e2nia are de recuperat un decalaj tehnologic de cel pu\u0163in 10 ani fa\u0163\u0103 de Europa Central\u0103. Spre deosebire de \u0163\u0103ri precum Polonia, Ungaria, Cehia \u015fi Slovenia care au dat importan\u0163\u0103 industriei farmaceutice \u015fi au investit \u00een acest sector economic, Rom\u00e2nia a regresat \u015fi a devenit un simplu importator de vaccinuri \u015fi medicamente, ajung\u00e2nd s\u0103 produc\u0103 mai pu\u0163in de 4% din consumul de medicamente al popula\u0163iei\u201d, a spus Drago\u015f Damian, director executiv al PRIMER \u015fi CEO al produc\u0103torului de medicamente Terapia Cluj, citat de Ziarul Financiar.<\/p>\n
\nPremierul Florin C\u00ee\u0163u anun\u0163a \u00een urm\u0103 cu dou\u0103 s\u0103pt\u0103m\u00e2ni c\u0103 Rom\u00e2nia va \u00eencerca s\u0103 produc\u0103 vaccin \u00eempotriva COVID la Institutul Cantacuzino, singurul centru \u00een care s-a produs vreodat\u0103 vaccin \u00een Rom\u00e2nia. Institutul, aflat \u00een prezent \u00een subordinea Ministerului Ap\u0103r\u0103rii, nu este \u00eens\u0103 adus la standardele tehnologice pentru a primi autoriza\u0163ie de produc\u0163ie, \u00een contextul \u00een care din 2015 nu mai produce nicio doz\u0103 de vaccin.<\/p>\n
\nPRIMER estimeaz\u0103 c\u0103 nu se vor putea fabrica vaccinuri sau medicamente noi mai devreme de trei ani, cu condi\u0163ia ca autorit\u0103\u0163ile s\u0103 investeasc\u0103 \u00een acest domeniu. \u201cDe mai bine de cinci ani, PRIMER propune o serie de m\u0103suri pe termen lung de sprijinire a produc\u0163iei de medicamente pe teritoriul \u0163\u0103rii. Am solicitat ca domeniul s\u0103 fie considerat de importan\u0163\u0103 strategic\u0103 pentru a beneficia de facilit\u0103\u0163i fiscale, aprobarea unui sistem de offset a taxei clawback pentru companiile care fac investi\u0163ii de capital precum \u015fi \u00eenfiin\u0163area unei Autorit\u0103\u0163i Na\u0163ionale a Medicamentului, care s\u0103 fie responsabil\u0103 de investi\u0163iile \u00een fabrici noi de medicamente \u015fi vaccinuri\u201d, a mai spus Drago\u015f Damian..<\/p>\n
\n\u00centre timp, \u0163\u0103ri precum Austria, Fran\u0163a \u015fi Ungaria \u00eencep s\u0103 acceseze fonduri europene \u015fi s\u0103 creeze situri mari de fabrica\u0163ie de vaccinuri \u015fi medicamente strategice pentru aprovizionarea \u00eentregii Uniuni Europene.<\/p>\n
\nHarta \u0163\u0103rilor \u00een care se produc cele trei tipuri de vaccinuri aprobate la nivelul Uniunii Europene \u2013 Pfizer, Moderna \u015fi Astrazeneca arat\u0103 dou\u0103 p\u0103r\u0163i ale continentului la extreme, pentru c\u0103 \u00een Europa de Est nu este nicio fabric\u0103 de\u0163inut\u0103 sau preluat\u0103 de cei trei gigan\u0163i, arat\u0103 o analiz\u0103 de pe site-ul publica\u0163iei Bloomberg.<\/p>\n
\nPRIMER reune\u015fte 19 fabrici importante de medicamente din \u0163ar\u0103, printre care Antibiotice, Biofarm, Fiterman Pharma, Ropharma, Terapia, Zentiva.<\/p>\n","protected":false},"excerpt":{"rendered":"
Patronatul Produc\u0103torilor Industriali de Medicamente din Rom\u00e2nia (PRIMER) atrage aten\u0163ia c\u0103 Rom\u00e2nia nu are capacitatea tehnologic\u0103 \u015fi nici personal pentru a putea \u00eencepe produc\u0163ia de vaccinuri \u00een \u0163ar\u0103, \u00een contextul \u00een care investi\u0163iile \u00een acest domeniu de cercetare au lipsit \u00een ultimii ani.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[10275,259],"class_list":["post-191009","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-fabrici","tag-productie"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/191009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=191009"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/191009\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=191009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=191009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=191009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}